Today, Bloomberg Businessweek published an investigative report detailing how Chinese shrimp contaminated by antibiotics was routed through Malaysia, falsely claimed to be a product of Malaysia, and imported into the United States through those false representations. The story, reported by Jason Gale, Lydia Mulvany, and Monte Reel, documents the abuse of antibiotics in raising both terrestrial and aquatic livestock in China, as well as the public health threat posed by the further spread of antibiotic-resistant bacteria. The story additionally describes how, in response to efforts to counteract transshipment of Chinese shrimp through Malaysia, new transshipment channels may have open up to facilitate the importation of cheap Chinese shrimp into the U.S. market under false pretenses.
John Williams, the Executive Director of the Southern Shrimp Alliance is quoted in the story discussing the challenges faced by federal enforcement agencies in trying to stop fraudulent shrimp import trade:
“The import alert was a huge step forward to prevent contaminated shrimp from getting to U.S. consumers, but we have also seen significant shifts in trade patterns indicating new routes and methods for getting bad shrimp into the U.S. market. . . . As long as there are distributors, retailers, and restaurants that, provided that the price is low, do not know and do not care where their shrimp is coming from, we expect to see shrimp-trade fraud.”
Please read the full BloombergBusinessweek story (“How Antibiotic-Tainted Seafood From China Ends Up on Your Table”) here: